The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictors of survival outcome of TAS102 combined with bevacizumab compared to TAS102 alone in Saudi patients with metastatic colorectal cancer beyond second line of systemic therapy.
 
Shereef Ahmed Elsamany
Honoraria - Merck Serono
Consulting or Advisory Role - SERVIER
Research Funding - Amgen
 
Hosam Alghanmi
No Relationships to Disclose
 
Emad M Tashkandi
Honoraria - SERVIER
Consulting or Advisory Role - Merck Serono
 
Ahmed Saleh Al-Shehri
Honoraria - SERVIER
Consulting or Advisory Role - Merck Sharp & Dohme
 
Fayza Hassanin
No Relationships to Disclose
 
Nashwa A. Abdulaziz
No Relationships to Disclose
 
Mai Alhowari
No Relationships to Disclose
 
Mervat Mahrous
Honoraria - SERVIER
Consulting or Advisory Role - Merck Sharp & Dohme
 
Mohammed Abdullah Alghamdi
No Relationships to Disclose